ETOPOSIDE — all Canadian products
13 DINs
3 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ETOPOSIDE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02552671 | ETOPOSIDE INJECTION | HIKMA CANADA LIMITED | Solution | Intravenous | ETOPOSIDE 20 MG | Marketed | |
| 02080036 | ETOPOSIDE INJECTION | TEVA CANADA LIMITED | Solution | Intravenous | ETOPOSIDE 20 MG | Marketed | |
| 00616192 | VEPESID | CHEPLAPHARM ARZNEIMITTEL GMBH | Capsule | Oral | ETOPOSIDE 50 MG | Marketed | |
| 02237872 | DOM-ETOPOSIDE | DOMINION PHARMACAL | Liquid | Intravenous | ETOPOSIDE 20 MG | Cancelled Pre Market | |
| 02237428 | EPOSIN | PHARMACHEMIE B.V. | Liquid | Intravenous | ETOPOSIDE 20 MG | Cancelled Pre Market | |
| 02237873 | ETOPOSIDE | PHARMEL INC | Liquid | Intravenous | ETOPOSIDE 20 MG | Cancelled Pre Market | |
| 02227509 | ETOPOSIDE - LIQ IV 20MG/ML | BDH INC. | Liquid | Intravenous | ETOPOSIDE 20 MG | Cancelled Post Market | |
| 02239961 | ETOPOSIDE INJECTION | FRESENIUS KABI CANADA LTD | Liquid | Intravenous | ETOPOSIDE 20 MG | Dormant | |
| 02380935 | ETOPOSIDE INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | Intravenous | ETOPOSIDE 20 MG | Cancelled Post Market | |
| 02241182 | ETOPOSIDE INJECTION, USP | HOSPIRA HEALTHCARE ULC | Solution | Intravenous | ETOPOSIDE 20 MG | Cancelled Post Market | |
| 02422530 | ETOPOSIDE INJECTION, USP | STRIDES PHARMA CANADA INC | Solution | Intravenous | ETOPOSIDE 20 MG | Dormant | |
| 02237871 | PMS-ETOPOSIDE | PHARMASCIENCE INC | Liquid | Intravenous | ETOPOSIDE 20 MG | Cancelled Pre Market | |
| 00523410 | VEPESID INJ 20MG/ML | BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | Liquid | Intravenous | ETOPOSIDE 20 MG | Cancelled Post Market |
Browse other molecules: